HCAT - NASDAQ
Health Catalyst, Inc.
$1.33
+1.9%Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
At a Glance
Live SnapshotHealth Catalyst, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Health Catalyst, Inc. Income Statement
HCAT • NASDAQ
| Health Catalyst, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
311.1M | 306.6M | 295.9M | 276.2M | 241.9M | 188.8M | 154.9M | 112.6M | 73.1M | |
GROSS PROFIT | |||||||||
(207M) | (165.8M) | (164.1M) | (143M) | (124.4M) | (98.1M) | (75.3M) | (59.9M) | (43.6M) | |
104.1M | 140.8M | 131.8M | 133.2M | 117.6M | 90.8M | 79.6M | 52.7M | 29.4M | |
OPERATING INCOME | |||||||||
(140.2M) | (210.6M) | (258.7M) | (273.2M) | (261.2M) | (186.9M) | (134.5M) | (112.8M) | (75M) | |
(102M) | (111.2M) | (143.9M) | (149.2M) | (161M) | (114.7M) | (79M) | (66.8M) | (40.6M) | |
(49.8M) | (58M) | (72.6M) | (75.7M) | (62.7M) | (53.5M) | (46.3M) | (38.6M) | (28.5M) | |
-36.1M | -69.8M | -126.9M | -140M | -143.7M | -96.1M | -54.9M | -60.1M | -45.5M | |
PRE-TAX INCOME | |||||||||
(16.4M) | (17.1M) | (7.3M) | (7.2M) | (17.3M) | (13.7M) | (6.3M) | (2.6M) | (2M) | |
-8.9M | 896K | 9.1M | -1.6M | -16.5M | -11.6M | -3.5M | -2M | -1.5M | |
-11.6M | (41.4M) | (42.2M) | (48.3M) | (37.5M) | (18.7M) | (9.2M) | -39K | -4K | |
-141.2M | 637K | 9.1M | -1.7M | -16.5M | -20.1M | -5.1M | -2M | -1.5M | |
-177.3M | -69.2M | -117.8M | -141.7M | -160.1M | -116.2M | -60M | -62.1M | -47M | |
NET INCOME | |||||||||
(716K) | (333K) | (356K) | -4.3M | -6.9M | -1.2M | (142K) | -135K | (26K) | |
-178M | -69.5M | -118.1M | -137.4M | -153.2M | -115M | -60.1M | -62M | -47M |
SEC Filings
HCAT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 11, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 24, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 03, 2026 | March 31, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 18, 2026 | February 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 23, 2026 | January 20, 2026 | 2026 |
Related Guides
Continue your HCAT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.